A practical reference on REV-ERB: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-07-04. Anything still debated is marked as such rather than presented as settled.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The cytoskeleton acts to organize and maintain the cell's shape; anchors organelles in place; helps during endocytosis, and in the uptake of external materials by a cell. The cytoskeleton is composed of microtubules, intermediate filaments and microfilaments. There are a great number of proteins associated with them, each controlling a cell's structure by directing, bundling, and aligning filaments. The outermost part of the cytoskeleton is the cell cortex, or actin cortex, a thin layer of cross-linked actomyosins. Its thickness varies with cell type and physiology. It directs the transport through the ER and the Golgi apparatus. The cytoskeleton in the animal cell also plays a part in cytokinesis, in the formation of the spindle apparatus during cell division, the separation of daughter cells.
Side-door vessels have water-tight ports on the ship's hull, which open into a cargo hold. Elevators or ramps leading from the quay serve as loading and discharging access for the forklifts or conveyors. Inside these access ports or side doors, pallet lifts or another series of conveyors bring the cargo to the respective decks. This special design makes the vessels particularly well suited for inclement weather operations as the tops of the cargo holds are always closed against rain and sun. Conventional vessels have a traditional cargo operation with top opening hatches and cranes/derricks. On such ships, when facing wet weather, the hatches need to be closed to prevent heavy rain from flooding the holds. Both above ship types are well suited for the handling of palletized and loose cargo. Refrigerated container ships are specifically designed to carry containerised unit loads where each container has its individual refrigerated unit. These containers are nearly always twenty-foot equivalent units (often called TEU) that are the size of "standard" cargo containers that are loaded and unloaded at container terminals and aboard container ships. These ships differ from conventional container ships in their design, power generation, and electrical distribution equipment. They need provisions made for powering each container's cooling system. Because of their ease of loading and unloading cargo many container ships are now being built or redesigned to carry refrigerated containers.
== Ownership == In 2013, Bain Capital acquired an 80% controlling interest in BPL, previously wholly owned by the UK Government. Three years later, the shareholders decided to sell BPL Holdings to Creat, an investment company based in Beijing that owns part of a plasma fractionator in China. In 2022, Permira and Marcucci entered into an agreement to acquire and merge BPL and Kedrion operations into one venture. As a result, the new company would inherit the shareholders of the companies involved, requiring the support of its co-investors. In this case, FSI, CDP Equity and the other Kedrion shareholders had their shares transferred to the new company. In turn, to complete the agreement, the family group received the support of its co-investors, Ampersand Capital Partners and a wholly owned subsidiary of Abu Dhabi Investment Authority (ADIA). In 2023, the BPL site became known as Kedrion Elstree although its product portfolio continued to be marketed as 'BPL'.
A vaccine to remove senescent cells, a key driver of the aging process, is demonstrated in mice by researchers from Japan. The American biotechnology company Altos Labs, which focuses on life extension research, is founded.
Sources: en.wikipedia.org
The signal change manifests itself in an increase or decrease in the current (electrical) or in a change in the intensity or wavelength of the fluorescence emission (optical). Depending on the type of application, both electrical or optical signal transmission can be advantageous. For sensitive measurement of electronic changes, field-effect transistors (FET) are often used in which the flow of charges within the SWCNTs is measured. The FET structures allow easy on-chip integration and can be parallelized to detect multiple target analytes simultaneously. However, such sensors are more invasive for in vivo applications, as the entire device has to be inserted into the body. Optical detection with semiconducting SWCNTs is based on the radiative recombination of excitons in the near-infrared (NIR) by prior optical (fluorescence) or electrical excitation (electroluminescence). The emission in the NIR enables detection in the biological transparency window, where optical sensor applications benefit from reduced scattering and autofluorescence of biological samples and consequently a high signal-to-noise ratio. Compared to optical sensors in the UV or visible range, the penetration depth in biological tissue is also increased. In addition to the advantage of a contactless readout SWCNTs have excellent photostability, which enables long-term sensor applications. Furthermore, the nanoscale size of SWCNTs allows dense coating of surfaces which enables chemical imaging, e.g. of cellular release processes with high spatial and temporal resolution.
=== 30 July === Russia claimed to have taken the village of Pivdenne, east of Toretsk. The Ukrainian 79th Tavrian Air Assault Brigade claimed to have repelled a major Russian assault on Kurakhove, inflicting losses of 12 armored vehicles, eight tanks, nine motorcycles, and one buggy destroyed, 36 Russian soldiers killed and 32 others injured. The Ukrainian military claimed to have struck an oil depot in Russia's Kursk Oblast following an air attack.
== Data recovery after the discontinuation of Peptidome == The NCBI Peptidome database was discontinued in 2011, yet a joint effort by the PRIDE and Peptidome teams resulted in the transfer of all Peptidome data to PRIDE.
Similar effects are known for related androgenic progestins like medroxyprogesterone acetate and megestrol acetate. CPA has also been reported to lower HDL cholesterol levels, another effect associated with androgens. Accordingly, CPA shows weak androgenic effects in the liver in rodents which can be blocked by flutamide.
In North Africa, the Wehrmacht shipped in fresh fruit from Italy and Greece to supplement its troops' rations, even during the Great Famine in Greece. The Imperial Japanese Army and Navy received rather basic rations, usually consisting of rice with barley, meat or fish, pickled or fresh vegetables, umeboshi, soy sauce, miso or bean paste, and green tea. The rations were intended to be eaten with other foraged food. Japanese soldiers were also issued emergency rations. The standard emergency ration, intended to last for five days, included a small sack of rice, package of compact food, package of hardtack, one-half pound (230 g) of hard candy, can of tea, and vitamin pills. Japanese soldiers also hunted dogs, goats, and other small animals to add to their emergency rations. In the Burma campaign, two types of emergency rations were used, "A" rations intended for three days consisting of 19 ounces (540 g) of rice and a small can of beef and vegetables, and "B" rations intended for one day consisting of three bags of hard biscuits. They were meant to be eaten only upon orders from a commanding officer when the unit was separated from its supply column. Japanese soldiers were often undersupplied. Japanese commanders had a cavalier attitude to food supplies for their troops and supply lines were often not protected. As a result, about 60% of Japanese military deaths during the war were due to starvation.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.